Abstract
The use of atherectomy in lower extremity arterial disease may be associated with higher rates of distal embolization and has not been shown to be superior to angioplasty or stenting for femoral-popliteal occlusive disease. Embolic protection devices (EPDs) have been used in femoral-popliteal interventions of all types at varying rates. There are important lesion characteristics to consider when weighing the risk of distal embolization, but we hypothesize that other characteristics may play a role as well.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
